Angioplasty

Cagent Vascular appoints Chairman Brian Walsh to expanded role as Chief Executive Officer

Retrieved on: 
화요일, 5월 7, 2024
Health, Surgery, Health Technology, Clinical Trials, General Health, Biotechnology, Sale, Economy, NVS, PAD, Angioplasty, Cardiovascular disease, Alcon, Community, Peripheral artery disease, Economic development, Growth, Head

Cagent Vascular announced today that Brian Walsh has been named Chief Executive Officer by the Cagent Vascular Board of Directors.

Key Points: 
  • Cagent Vascular announced today that Brian Walsh has been named Chief Executive Officer by the Cagent Vascular Board of Directors.
  • Mr. Walsh previously served as Head of Carl Zeiss Meditech Cataract Technology from 2018 until 2024.
  • Brian Walsh brings over 25 years of medical device and health care industry experience in Marketing, Sales, and Executive Leadership which positions him as the ideal candidate to drive the market adoption of Cagent Vascular’ s flagship product, Serranator.
  • “Cagent Vascular is an exceptional company with a disruptive technology platform and a highly talented team,” Mr. Walsh said.

Intermountain McKay Dee Hospital and Intermountain Medical Center Named to Fortune's 2024 Top 50 Heart Hospitals List

Retrieved on: 
금요일, 4월 12, 2024
Hospital, Cardiology, MD, Patient, Angioplasty, Health facility, Fortune (magazine), Medicare, Death, Intermountain Medical Center, Intermountain Health, Nursing

SALT LAKE CITY and OGDEN, Utah, April 12, 2024 (GLOBE NEWSWIRE) -- Two Intermountain Health facilities have been named 2024 Top 50 Heart Hospitals in the U.S. by Fortune Magazine.

Key Points: 
  • SALT LAKE CITY and OGDEN, Utah, April 12, 2024 (GLOBE NEWSWIRE) -- Two Intermountain Health facilities have been named 2024 Top 50 Heart Hospitals in the U.S. by Fortune Magazine.
  • Intermountain McKay-Dee Hospital in Ogden, Utah and Intermountain Medical Center in Murray are ranked as two of the nation’s Top 50 Cardiovascular Hospitals for 2024 by Fortune and Pinc AI, which evaluates heart hospitals annually to determine facilities that are excelling in providing high quality, affordable heart care.
  • The Fortune and Pinc AI rankings including teaching hospitals with and without cardiovascular residency programs, along with community hospitals.
  • This is the fourth time in a row that Intermountain Medical Center has been named to the Fortune Top 50 list, and the first year for Intermountain McKay-Dee Hospital.

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte™ Image Guided Crossing and Re-Entry Catheter System

Retrieved on: 
목요일, 4월 11, 2024
Medical Devices, FDA, Health, Health Technology, Radiology, Cardiology, Operational technology, Catheter, American College, Coronary artery disease, Food, MD, Angioplasty, Interventions, OCT, Patient, Diagnosis, Plaque, Journal, Medical imaging

Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
  • The Acolyte Image Guided Crossing and Re-Entry Catheter System aims to overcome these challenges by providing clinicians with this breakthrough device that has enhanced visualization and navigation capabilities, ultimately improving CTO crossing, procedural success rates, and patient outcomes.
  • "We are thrilled to receive FDA's Breakthrough Device Designation for our Acolyte Image Guided Crossing and Re-Entry Catheter System," said Dr. John B. Simpson, PhD, MD, Founder and CEO of Simpson Interventions.
  • Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System.

ZOLL Receives Innovative Technology Contract from Vizient for TherOx SuperSaturated Oxygen (SSO2) Therapy

Retrieved on: 
화요일, 4월 2, 2024
Surgery, Medical Devices, Hospitals, Health, Cardiology, Angioplasty, Asahi Kasei, Patient, Cardiac muscle, Facial muscles, Mortality, Splenic infarction, AUC, STEMI, LAD, Heart, Safety, Patient safety, FDA, Nursing

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has received an Innovative Technology contract from Vizient, Inc. , the nation’s largest provider-driven healthcare performance improvement company.

Key Points: 
  • ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has received an Innovative Technology contract from Vizient, Inc. , the nation’s largest provider-driven healthcare performance improvement company.
  • Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program.
  • Through its Innovative Technology Program , Vizient works with customer-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare.
  • Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

Global Balloon Catheter Market Analysis Report 2023-2030: Minimally Invasive Solutions and Age-Associated Cardiovascular Problems Drive Demand - ResearchAndMarkets.com

Retrieved on: 
금요일, 3월 22, 2024
Medical Supplies, Medical Devices, Health, Surgery, Cardiology, Biotechnology, Coronary artery disease, Balloon catheter, Neurology, Prevalence, Headache, Urbanization, Blood, Peripheral artery disease, Urology, Angioplasty, Nylon, Hospital, Restenosis, Research, Splenic infarction, Telehealth, Heart, Stroke, Artery, Safety, Prognosis, Catheter, FDA, Artificial intelligence, CAD, Ageing, Medical device

The "Global Balloon Catheter Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Balloon Catheter Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The growing prevalence of age-associated cardiovascular problems propels balloon catheter demand, significantly increasing the medical device market and enhancing the care of growing older populations globally.
  • Offering minimally invasive alternatives to conventional surgeries, balloon catheters lead to faster recuperation instances, decreased dangers, and progressed patient effects, driving market increase towards minimally invasive tactics.
  • By product type, the Global Balloon Catheter Market is divided into Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter, Stent Graft Balloon Catheter, and Others.

Lee Health’s HealthPark Medical Center Named Among the Top 50 Hospitals for Heart Care in the U.S. for the 11th Time

Retrieved on: 
화요일, 2월 20, 2024
Hospital, CABG, AMI, Cardiology, IBM, IBM Watson, Heart failure, Angioplasty, Health care, Organization, Patient, Cardiac rehabilitation, Survival, HF, PCI, Nursing

Formerly known as the IBM Watson award, the PINC AI™ 50 Top Cardiovascular Hospitals™ represent the highest standard of cardiovascular care in the United States.

Key Points: 
  • Formerly known as the IBM Watson award, the PINC AI™ 50 Top Cardiovascular Hospitals™ represent the highest standard of cardiovascular care in the United States.
  • HealthPark Medical Center is one of only five hospitals in Florida and the only hospital in Southwest Florida to earn the designation.
  • The 2024 PINC AI™ 50 Top Cardiovascular Hospitals™ provide higher quality clinical care and are more efficient than their peers.
  • The PINC AI™ 50 Top Cardiovascular Hospitals™ program focuses on short-term, acute care, non-federal U.S. hospitals that treat a broad spectrum of cardiology patients.

Global Pediatric Interventional Cardiology Market Forecast 2024-2030: PIC Market Forecast for 6.36% CAGR Between 2024 to 2030 - ResearchAndMarkets.com

Retrieved on: 
목요일, 2월 29, 2024
General Health, Health, Cardiology, Heart, Incidence, Procedure, Catheter, Birth defect, Investment, Physician, Moyamoya disease, Congenital heart defect, Projection, VSD, Angioplasty, Prevalence, CHD, Coronary thrombosis, Atherectomy, Patient, Stent, Ventricular septal defect, CDC, Catheter ablation, Research, Medical imaging

The Pediatric Interventional Cardiology Market is forecasted to reach US$ 3.91 Billion through 2030.

Key Points: 
  • The Pediatric Interventional Cardiology Market is forecasted to reach US$ 3.91 Billion through 2030.
  • The pediatric interventional cardiology market proportion is expanding swiftly, driven by the rising prevalence of cardiac disorders in children and technological advancements.
  • The Stents segment is anticipated to dominate the global pediatric interventional cardiology market throughout the forecast period.
  • The comprehensive infrastructure of hospitals, coupled with their ability to provide diverse pediatric cardiology services, positions them as key contributors to the growth and development of the Pediatric Interventional Cardiology market.

PINC AI™ and Fortune Name the Nation’s 50 Top Cardiovascular Hospitals™

Retrieved on: 
목요일, 2월 15, 2024
Cardiology, Software, General Health, Health, Artificial Intelligence, Hospitals, Health Technology, Technology, Hospital, CABG, AMI, Death, Risk, Heart failure, Angioplasty, Health care, Medicare, Organization, Patient, Survival, HF, Mortality, Premier, PCI, Nursing

PINC AI™, the technology and services brand of Premier, Inc. (NASDAQ: PINC), today announced the nation’s 50 Top Cardiovascular Hospitals™.

Key Points: 
  • PINC AI™, the technology and services brand of Premier, Inc. (NASDAQ: PINC), today announced the nation’s 50 Top Cardiovascular Hospitals™.
  • To create the list, an objective, quantitative analysis of publicly available data was conducted to identify the top cardiovascular hospitals in the United States.
  • The primary purpose of the PINC AI™ 50 Top Cardiovascular Hospitals™ program is to inspire hospital and health system leaders to pursue higher performance and deliver added value to patients and communities.
  • Compared to their peers, this year’s top performers had:
    28 percent fewer acute myocardial infarction (AMI) deaths and 50 percent fewer coronary artery bypass grafting (CABG) deaths.

Digital Health Market Worth $549.7 Billion | MarketsandMarkets

Retrieved on: 
화요일, 11월 14, 2023
Conditional sentence, Patient safety, Privacy, Investment, Patient, Apple Inc., FCC v. AT&T Inc., Growth, MHealth, Diabetes, Demand, GE HealthCare, Prevalence, CSI, Fitbit, Roe, Ageing, AI, MEA, Atherectomy, Exercise, Omron, Research, Angioplasty, COVID-19, Software, Pulse, Medical device, Pharmaceutical industry, Video game, Mobile phone, Medtronic

Based on technology, the digital health market is segmented into telehealthcare, mHealth, health management solutions and digital therapeutics.

Key Points: 
  • Based on technology, the digital health market is segmented into telehealthcare, mHealth, health management solutions and digital therapeutics.
  • On the basis of application, the digital health market is segmented into chronic disease management, behavioral health, health & fitness and others.
  • ·  Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital health market.
  • ·  Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital health market.

Digital Health Market Worth $549.7 Billion | MarketsandMarkets

Retrieved on: 
화요일, 11월 14, 2023
Conditional sentence, Patient safety, Privacy, Investment, Patient, Apple Inc., FCC v. AT&T Inc., Growth, MHealth, Diabetes, Demand, GE HealthCare, Prevalence, CSI, Fitbit, Roe, Ageing, AI, MEA, Atherectomy, Exercise, Omron, Research, Angioplasty, COVID-19, Software, Pulse, Medical device, Pharmaceutical industry, Video game, Mobile phone, Medtronic

Based on technology, the digital health market is segmented into telehealthcare, mHealth, health management solutions and digital therapeutics.

Key Points: 
  • Based on technology, the digital health market is segmented into telehealthcare, mHealth, health management solutions and digital therapeutics.
  • On the basis of application, the digital health market is segmented into chronic disease management, behavioral health, health & fitness and others.
  • ·  Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital health market.
  • ·  Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital health market.